Yahoo! News published news that  Sequential Skin raised US $1.65M in oversubscribed seed round to revolutionise skin health with their novel skin microbiome testing kit. 

Sequential Skin (SOSV IBNY02 2021) provides personalized skincare by using advanced genetic sequencing technology to analyze how genes, skin microbiome, and the environment interact and affect an individual’s skin.

Led by Metaplanet and joined by Scrum Ventures, SOSV, Genedant, and angel investor Ben Holmes, the press release explains “the funding will significantly boost their IP portfolio, using their novel patch-based, skin analysis, to develop further tools to understand how your genetics, epigenetics, and skin microbiome, affect health and disease.”

About Sequential Skin’s mission, the company’s CSO and co-founder Dr. Albert Dashi said, “Our scope is to provide science to people and empower them with the right tools and knowledge so they make the right decision for the future of their skin health and well-being.”